Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Sponsor: Novartis Pharmaceuticals
Summary
This open-label extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent study (CTQJ230A12301).
Official title: A Single Arm, Multicenter, Open-label Extension (OLE) Trial to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) in Participants Who Completed the Parent Lp(a)HORIZON Trial
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
5700
Start Date
2026-04-13
Completion Date
2030-01-09
Last Updated
2026-04-08
Healthy Volunteers
No
Interventions
Pelacarsen (TQJ230)
pelacarsen 80mg s.c. monthly
Locations (72)
UCSF
San Francisco, California, United States
Helping Hands Medical Associates INC
Santa Ana, California, United States
Manshadi Heart Institute
Stockton, California, United States
Interv Cardiology Med Grp
West Hills, California, United States
Wayne State University
Detroit, Michigan, United States
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
Cardiology Consultants of Philadelphia
Yardley, Pennsylvania, United States
Inova Fairfax Hospital
Falls Church, Virginia, United States
Novartis Investigative Site
Mar del Plata, Buenos Aires, Argentina
Novartis Investigative Site
Huy, Belgium
Novartis Investigative Site
Santo André, São Paulo, Brazil
Novartis Investigative Site
São Paulo, São Paulo, Brazil
Novartis Investigative Site
San Gil, Colombia
Novartis Investigative Site
Kroměříž, Czech Republic, Czechia
Novartis Investigative Site
Brno, Czechia
Novartis Investigative Site
Brno, Czechia
Novartis Investigative Site
Broumov, Czechia
Novartis Investigative Site
Český Krumlov, Czechia
Novartis Investigative Site
Kolín, Czechia
Novartis Investigative Site
Most, Czechia
Novartis Investigative Site
Ostrava, Czechia
Novartis Investigative Site
Pardubice, Czechia
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Trutnov, Czechia
Novartis Investigative Site
Uherské Hradiště, Czechia
Novartis Investigative Site
Valašské Meziříčí, Czechia
Novartis Investigative Site
Frankfurt am Main, Hesse, Germany
Novartis Investigative Site
Hanover, Lower Saxony, Germany
Novartis Investigative Site
Jena, Thuringia, Germany
Novartis Investigative Site
Dortmund, Germany
Novartis Investigative Site
Essen, Germany
Novartis Investigative Site
Lüneburg, Germany
Novartis Investigative Site
Magdeburg, Germany
Novartis Investigative Site
Meissen, Germany
Novartis Investigative Site
München, Germany
Novartis Investigative Site
Dehradun, Uttarakhand, India
Novartis Investigative Site
Haifa, Israel
Novartis Investigative Site
Bergamo, BG, Italy
Novartis Investigative Site
Brescia, BS, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Rozzano, MI, Italy
Novartis Investigative Site
Tiel, Gelderland, Netherlands
Novartis Investigative Site
Sneek, Provincie Friesland, Netherlands
Novartis Investigative Site
Baia Mare, Maramureş, Romania
Novartis Investigative Site
Buzău, Romania
Novartis Investigative Site
Bardejov, Slovakia
Novartis Investigative Site
Handlová, Slovakia
Novartis Investigative Site
Lučenec, Slovakia
Novartis Investigative Site
Piešťany, Slovakia
Novartis Investigative Site
Prešov, Slovakia
Novartis Investigative Site
Rimavská Sobota, Slovakia
Novartis Investigative Site
Svidník, Slovakia
Novartis Investigative Site
Badalona, Barcelona, Spain
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, Spain
Novartis Investigative Site
Cáceres, Extremadura, Spain
Novartis Investigative Site
A Coruña, Spain
Novartis Investigative Site
Córdoba, Spain
Novartis Investigative Site
Huelva, Spain
Novartis Investigative Site
Málaga, Spain
Novartis Investigative Site
Seville, Spain
Novartis Investigative Site
Lausanne, Switzerland
Novartis Investigative Site
Liestal, Switzerland
Novartis Investigative Site
Izmir, Balcova, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site
Istanbul, Kadikoy, Turkey (Türkiye)
Novartis Investigative Site
Eskişehir, Odunpazari, Turkey (Türkiye)
Novartis Investigative Site
Mersin, Yenisehir, Turkey (Türkiye)
Novartis Investigative Site
Izmir, Turkey (Türkiye)
Novartis Investigative Site
Newport, United Kingdom
Novartis Investigative Site
Sheffield, United Kingdom